Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn&apos;s Disease

Inflammatory Bowel Disease

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease

Gastroenterology

Scott FI, Ananthakrishnan AN, Click B, Agrawal M, Syal G, Haydek JP, Yuan Y, Kappelman MD, Lewis JD, Singh S

doi: 10.1053/j.gastro.2025.09.038

Inflammatory Bowel Disease

Treatment and Outcomes of Crohn's Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007-23

Clin Gastroenterol Hepatol

Ahuja D, Park SK, Qi Y, Patel SB, Jairath V, Xu R, Boland BS, Lewis JD, Kappelman MD, Goodwin SW, Singh S

doi: 10.1016/j.cgh.2026.04.006

Inflammatory Bowel Disease

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial

J Crohns Colitis

Bhandari M, Sharip MT, Noor NM, Khwaja S, Paverd H, De Paepe KN, Godfrey E, Hickman K, Patel KV, Subramanian S, Raine T, Lee JC, Kennedy NA, Upponi S, Parkes M, PROFILE Study Group

doi: 10.1093/ecco-jcc/jjag056

Inflammatory Bowel Disease

Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis

Inflamm Bowel Dis

Gan X, Zhang Y, Zhang Y, Ye Z, Yang S, Xiang H, Huang Y, Wu Y, Zhang Y, Qin X

doi: 10.1093/ibd/izaf325

Inflammatory Bowel Disease

Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update

J Crohns Colitis

Shouval DS, Hojsak I, Miele E, Sokollik C, Turner D, Kolho KL, Sigall-Boneh R, van Rheenen PF, Wine E, Russell RK, Hussey S, Chanchlani N, Assa A, Martin de Carpi J, Scarallo L, Griffiths AM, Yerushalmy-Feler A, Strisciuglio C, de Ridder L, Bronsky J, Gordon H, Adamina M, Escher JC, Gasparetto M, Gianolio L, Wilson DC, Aloi M

doi: 10.1093/ecco-jcc/jjag084

Inflammatory Bowel Disease

Long-term safety of vedolizumab in patients with ulcerative colitis/Crohn's disease: A prospective observational study

Clin Gastroenterol Hepatol

Louis E, Sebastian S, Siegmund B, Bossuyt P, Danese S, de Boer N, Loftus EV, Moum B, Peyrin-Biroulet L, Schreiber S, Zhou J, Angellotti E, Adsul S, Jones S, Siegel CA

doi: 10.1016/j.cgh.2025.10.006

Esophagus Diseases

AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus

Gastroenterology

Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, Sultan S, Singh S, Inadomi J, Thrift AP, Katzka DA, Davitkov P

doi: 10.1053/j.gastro.2025.09.012

Inflammatory Bowel Disease

Janus Kinase Inhibitors for Inflammatory Bowel Disease: Concise Questions and Answers on Their Use in Clinical Practice

Inflamm Bowel Dis

Gisbert JP, Chaparro M

doi: 10.1093/ibd/izaf273

Inflammatory Bowel Disease

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study

J Crohns Colitis

Neri B, Schiavone SC, Mancone R, Fiorillo M, Fonsi A, Calabrese E, Perugini L, Piccione G, Di Matteo FM, Marafini I, Lolli E, Sica GS, Monteleone G, Biancone L

doi: 10.1093/ecco-jcc/jjaf163

Related content

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease

Treatment and Outcomes of Crohn's Disease and Ulcerative Colitis in Newly Diagnosed Adults in the United States, 2007-23

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial

Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis

Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update

Long-term safety of vedolizumab in patients with ulcerative colitis/Crohn's disease: A prospective observational study

AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus

Janus Kinase Inhibitors for Inflammatory Bowel Disease: Concise Questions and Answers on Their Use in Clinical Practice

Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study